HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Paloneva BM, J. Articles by Haltia, M. Search for Related Content PubMed PubMed Citation Articles by Paloneva BM, J. Articles by Haltia, M. Related Collections All Cognitive Disorders/Dementia

CNS manifestations of Nasu–Hakola disease

A frontal dementia with bone cysts

From the Department of Human Molecular Genetics (Dr. Paloneva), National Public Health Institute, Helsinki; Department of Radiology (Drs. Autti and Salonen), Helsinki University Central Hospital; Departments of Clinical Neurophysiology (Dr. Partanen), Radiology (Dr. Puranen), and Forensic Psychiatry (Dr. Hakola), University Hospital of Kuopio; Department of Pathology (Dr. Haltia), University of Helsinki and Helsinki University Central Hospital, Finland; and Department of Radiology (Dr. Raininko), Uppsala University, Sweden.

Address correspondence and reprint requests to Dr. Matti Haltia, Department of Pathology, University of Helsinki, Haartmaninkatu 3, FIN-00290 Helsinki, Finland; e-mail: matti.j.haltia{at}helsinki.fi

Background: Nasu-Hakola disease or polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) is a genetically heterogeneous disease characterized by a combination of systemic bone cysts and dementia. Objective: The authors present a neurologic, neuroradiologic, and neuropathologic analysis of a series of PLOSL patients in which the diagnosis has been confirmed by molecular genetic methods. Methods: Clinical, neurophysiologic, and imaging follow-up data on eight patients as well as autopsy samples of three patients were analyzed in this study. All eight patients were homozygous for a loss-of-function mutation in the DAP12 gene. Results: In most patients, the disease debuted with pain in ankles and wrists after strain during the third decade, followed by fractures caused by cystic lesions in the bones of the extremities. Frontal lobe syndrome and dementia began to develop by age 30, leading to death by age 40. Neuroimaging disclosed abnormally high and progressively increasing bicaudate ratios and calcifications in the basal ganglia as well as increased signal intensities of the white matter on T2-weighted MR images even before the appearance of clinical neurologic symptoms. Three patients who had undergone autopsies showed an advanced sclerosing leukoencephalopathy with frontal accentuation, widespread activation of microglia, and microvascular changes. Conclusions: Although PLOSL in most patients manifests by bone fractures, some patients do not show any osseous symptoms and signs before the onset of neurologic manifestations. Consequently, patients with frontal-type dementia of unknown origin should be investigated by x-ray of ankles and wrists. The current results suggest early basal ganglia involvement in PLOSL.

This article has been cited by other articles:

				H. H. Klunemann, B. H. Ridha, L. Magy, J. R. Wherrett, D. M. Hemelsoet, R. W. Keen, J. L. De Bleecker, M. N. Rossor, J. Marienhagen, H. E. Klein, et al. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2 Neurology, May 10, 2005; 64(9): 1502 - 1507. [Abstract] [Full Text] [PDF]

				K. Takahashi, C. D.P. Rochford, and H. Neumann Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 J. Exp. Med., February 22, 2005; 201(4): 647 - 657. [Abstract] [Full Text] [PDF]

				S. Nataf, A. Anginot, C. Vuaillat, L. Malaval, N. Fodil, E. Chereul, J.-B. Langlois, C. Dumontel, G. Cavillon, C. Confavreux, et al. Brain and Bone Damage in KARAP/DAP12 Loss-of-Function Mice Correlate with Alterations in Microglia and Osteoclast Lineages Am. J. Pathol., January 1, 2005; 166(1): 275 - 286. [Abstract] [Full Text] [PDF]

				A. Roumier, C. Bechade, J.-C. Poncer, K.-H. Smalla, E. Tomasello, E. Vivier, E. D. Gundelfinger, A. Triller, and A. Bessis Impaired Synaptic Function in the Microglial KARAP/DAP12-Deficient Mouse J. Neurosci., December 15, 2004; 24(50): 11421 - 11428. [Abstract] [Full Text] [PDF]

				E L Sampson, J D Warren, and M N Rossor Young onset dementia Postgrad. Med. J., March 1, 2004; 80(941): 125 - 139. [Abstract] [Full Text] [PDF]

				J. Paloneva, J. Mandelin, A. Kiialainen, T. Bohling, J. Prudlo, P. Hakola, M. Haltia, Y. T. Konttinen, and L. Peltonen DAP12/TREM2 Deficiency Results in Impaired Osteoclast Differentiation and Osteoporotic Features J. Exp. Med., August 18, 2003; 198(4): 669 - 675. [Abstract] [Full Text] [PDF]

				D Soragna, R Tupler, M T Ratti, L Montalbetti, L Papi, and R Sestini An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(6): 825 - 826. [Full Text] [PDF]

				T. Kondo, K. Takahashi, N. Kohara, Y. Takahashi, S. Hayashi, H. Takahashi, H. Matsuo, M. Yamazaki, K. Inoue, K. Miyamoto, et al. Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): Three genetic forms Neurology, October 8, 2002; 59(7): 1105 - 1107. [Abstract] [Full Text] [PDF]